Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Oct. 31, 2011	Oct. 31, 2010	Oct. 31, 2009
Cash flows from operating activities:
Net (loss) income	$ (3,976,043)	$ 488,134	$ (27,520,624)
Adjustments to reconcile net (loss) income to cash provided by operating activities:
Depreciation and amortization	4,086,377	4,300,662	5,244,938
(Gain) loss on sale of assets	(35,486)	15,490	(55,719)
(Gain) on early extinguishment of debt from a related party	(1,337,846)	0	0
Deferred income taxes	(2,024,921)	14,169	(13,957,990)
Deferred financing costs	436,855	372,610	309,471
Bad debt expense	269,612	370,333	876,145
Intangible impairment	8,716,868	0	41,127,483
Asset Impairment	109,255	0	206,170
Restructuring charges	571,746	1,812,325	0
(Gain)/Loss on hedging agreements	0	(691,368)	577,736
Changes in assets and liabilities:
Accounts receivable	(915,456)	(79,771)	4,588,233
Deferred revenue	17,199	47,181	(63,499)
Inventories	792,607	1,471,644	852,141
Other current assets	80,076	272,942	(92,053)
Accounts payable	1,078,579	(1,295,890)	(207,527)
Accrued payroll and commissions	(377,340)	(277,049)	(333,940)
Taxes accrued and withheld	70,173	(265,992)	404,333
Accrued income taxes	27,000	1,875,107	(1,200,304)
Accrued expenses	(567,031)	(461,118)	544,710
Other liabilities	(1,800)	(1,800)	(1,800)
Net cash provided by operating activities	7,020,424	7,967,609	11,297,904
Cash flows from investing activities:
Purchase of property and equipment	(866,402)	(396,157)	(1,993,029)
Proceeds from sale of fixed assets	320,083	32,256	160,324
Change in other assets	5,147	7,753	5,168
Cash surrender value proceeds	0	0	874,397
Net cash used in investing activities	(541,172)	(356,148)	(953,140)
Cash flows from financing activities:
Borrowings on line of credit	33,540,000	52,260,000	600,000
Payments on line of credit	(34,240,000)	(50,560,000)	(1,000,000)
Increase (decrease) in negative book cash balances	140,218	1,013,713	(986,704)
Principal payments on long-term debt	(5,919,470)	(11,043,871)	(7,199,497)
Deferred financing costs	0	(440,585)	0
Dividends paid	0	0	(599,281)
Net cash used in financing activities	(6,479,252)	(8,770,743)	(9,185,482)
Net (decrease) increase in cash and cash equivalents	0	(1,159,282)	1,159,282
Cash and cash equivalents at beginning of year	0	1,159,282	0
Cash and cash equivalents at end of year	$ 0	$ 0	$ 1,159,282